10-Q Filing

BIO-PATH HOLDINGS, INC. CIK: 1133818 Q1 2013

Filing Information

Form Type	10-Q
Accession Number	`0001144204-13-029373`
Period End Date	20130331
Filing Date	20130515
Fiscal Year	2013
Fiscal Period	Q1
XBRL Instance	bpth-20130331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 67 Income Statement 40 Cash Flow Statement 71

Balance Sheet 67 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash	`Cash`	$288.71K	USD	Point-in-time
Cash	`Cash`	$576.82K	USD	Point-in-time
Cash	`Cash`	$534.05K	USD	Point-in-time
Cash	`Cash`	-	USD	Point-in-time
Cash	`Cash`	$952.25K	USD	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid drug product for testing	`OtherInventory`	$195.00K	USD	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid drug product for testing	`OtherInventory`	$96.00K	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$53.92K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$42.58K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$771.62K	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$438.63K	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	62.22M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	62.22M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	62.22M	shares	Point-in-time
Technology licenses - related party	`FiniteLivedLicenseAgreementsGross`	$2.50M	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	62.22M	shares	Point-in-time
Technology licenses - related party	`FiniteLivedLicenseAgreementsGross`	$2.50M	USD	Point-in-time
Less Accumulated Amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$968.39K	USD	Point-in-time
Less Accumulated Amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$928.23K	USD	Point-in-time
Additional paid in capital for shares to be issued, shares of common stock	`CommonStockIssuableSharesIssuable`	2.54M	shares	Point-in-time
Additional paid in capital for shares to be issued, shares of common stock	`CommonStockIssuableSharesIssuable`	3.70M	shares	Point-in-time
Intangible Assets, Net (Excluding Goodwill), Total	`IntangibleAssetsNetExcludingGoodwill`	$1.53M	USD	Point-in-time
Intangible Assets, Net (Excluding Goodwill), Total	`IntangibleAssetsNetExcludingGoodwill`	$1.57M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$2.34M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$1.97M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$57.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$71.88K	USD	Point-in-time
Accounts payable - related party	`AccountsPayableRelatedPartiesCurrent`	$8.58K	USD	Point-in-time
Accounts payable - related party	`AccountsPayableRelatedPartiesCurrent`	-	USD	Point-in-time
Accrued expense	`AccruedLiabilitiesCurrent`	$153.54K	USD	Point-in-time
Accrued expense	`AccruedLiabilitiesCurrent`	$137.66K	USD	Point-in-time
Accrued expense - related party	`AccruedLiabilitiesRelatedPartiesCurrent`	$26.00K	USD	Point-in-time
Accrued expense - related party	`AccruedLiabilitiesRelatedPartiesCurrent`	$15.00K	USD	Point-in-time
Accrued license payments - related party	`DueToRelatedPartiesCurrent`	$100.00K	USD	Point-in-time
Accrued license payments - related party	`DueToRelatedPartiesCurrent`	$50.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$329.24K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$290.42K	USD	Point-in-time
Long term debt	`LongTermDebtNoncurrent`	-	USD	Point-in-time
Long term debt	`LongTermDebtNoncurrent`	-	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$329.24K	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$290.42K	USD	Point-in-time
Preferred Stock, $.001 par value 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred Stock, $.001 par value 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common Stock, $.001 par value, 200,000,000 shares authorized 62,219,050 shares issued and outstanding as of 3/31/13 and 12/31/12	`CommonStockValue`	$62.22K	USD	Point-in-time
Common Stock, $.001 par value, 200,000,000 shares authorized 62,219,050 shares issued and outstanding as of 3/31/13 and 12/31/12	`CommonStockValue`	$62.22K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$13.30M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$13.32M	USD	Point-in-time
Additional paid in capital for shares to be issued	`OtherAdditionalCapital`	$762.51K	USD	Point-in-time
Additional paid in capital for shares to be issued	`OtherAdditionalCapital`	$1.11M	USD	Point-in-time
Accumulated deficit during development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$12.79M	USD	Point-in-time
Accumulated deficit during development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$12.13M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$2.01M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$1.68M	USD	Point-in-time
TOTAL LIABILITIES & SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$1.97M	USD	Point-in-time
TOTAL LIABILITIES & SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$2.34M	USD	Point-in-time

Income Statement 40 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	-	USD	24 Qtrs
Revenue	`Revenues`	-	USD	1 Quarter
Amortization	`AdjustmentForAmortization`	$40.16K	USD	1 Quarter
Amortization	`AdjustmentForAmortization`	$1.02M	USD	24 Qtrs
Amortization	`AdjustmentForAmortization`	$48.11K	USD	1 Quarter
Revenue	`Revenues`	-	USD	1 Quarter
General & administrative	`GeneralAndAdministrativeExpense`	$7.30M	USD	24 Qtrs
General & administrative	`GeneralAndAdministrativeExpense`	$231.31K	USD	1 Quarter
General & administrative	`GeneralAndAdministrativeExpense`	$239.81K	USD	1 Quarter
Total operating expense	`OperatingExpenses`	$655.91K	USD	1 Quarter
Total operating expense	`OperatingExpenses`	$13.10M	USD	24 Qtrs
Technology impairment charge	`OtherAssetImpairmentCharges`	-	USD	1 Quarter
Technology impairment charge	`OtherAssetImpairmentCharges`	$690.00K	USD	24 Qtrs
Technology impairment charge	`OtherAssetImpairmentCharges`	-	USD	1 Quarter
Technology impairment charge	`OtherAssetImpairmentCharges`	$345.00K	USD	Annual
Total operating expense	`OperatingExpenses`	$522.63K	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-522.63K	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-13.10M	USD	24 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-655.91K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$77.21K	USD	24 Qtrs
Interest income	`InvestmentIncomeInterest`	$124.00	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$529.00	USD	1 Quarter
Other income	`OtherNonoperatingIncome`	-	USD	1 Quarter
Other income	`OtherNonoperatingIncome`	-	USD	1 Quarter
Other income	`OtherNonoperatingIncome`	$244.48K	USD	24 Qtrs
Other expense	`OtherNonoperatingExpense`	$129.00	USD	1 Quarter
Other expense	`OtherNonoperatingExpense`	$4.39K	USD	24 Qtrs
Other expense	`OtherNonoperatingExpense`	$216.00	USD	1 Quarter
Total Other Income (Expense)	`NonoperatingIncomeExpense`	$400.00	USD	1 Quarter
Total Other Income (Expense)	`NonoperatingIncomeExpense`	$-92.00	USD	1 Quarter
Total Other Income (Expense)	`NonoperatingIncomeExpense`	$317.30K	USD	24 Qtrs
Net Loss	`NetIncomeLoss`	$-522.23K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-12.79M	USD	24 Qtrs
Net Loss	`NetIncomeLoss`	$-656.00K	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.27	USD	24 Qtrs
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	46.73M	shares	24 Qtrs
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	62.22M	shares	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	58.38M	shares	1 Quarter

Cash Flow Statement 71 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-522.23K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-12.79M	USD	24 Qtrs
Net loss	`NetIncomeLoss`	$-656.00K	USD	1 Quarter
Amortization	`AdjustmentForAmortization`	$40.16K	USD	1 Quarter
Amortization	`AdjustmentForAmortization`	$1.02M	USD	24 Qtrs
Amortization	`AdjustmentForAmortization`	$48.11K	USD	1 Quarter
Technology impairment	`OtherAssetImpairmentCharges`	-	USD	1 Quarter
Technology impairment	`OtherAssetImpairmentCharges`	$690.00K	USD	24 Qtrs
Technology impairment	`OtherAssetImpairmentCharges`	-	USD	1 Quarter
Technology impairment	`OtherAssetImpairmentCharges`	$345.00K	USD	Annual
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	1 Quarter
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	1 Quarter
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$318.50K	USD	24 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$708.60K	USD	1 Quarter
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$318.50K	USD	21 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$795.00K	USD	1 Quarter
Stock options and warrants	`ShareBasedCompensation`	$16.02K	USD	1 Quarter
Stock options and warrants	`ShareBasedCompensation`	$19.36K	USD	1 Quarter
Stock options and warrants	`ShareBasedCompensation`	$3.03M	USD	24 Qtrs
Prepaid drug product for testing	`IncreaseDecreaseInInventories`	$-96.00K	USD	24 Qtrs
Prepaid drug product for testing	`IncreaseDecreaseInInventories`	$99.00K	USD	1 Quarter
Prepaid drug product for testing	`IncreaseDecreaseInInventories`	$132.00K	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-53.92K	USD	24 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-7.89K	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-11.35K	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-38.83K	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-69.54K	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$290.42K	USD	24 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-7.59M	USD	24 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-400.19K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-551.00K	USD	1 Quarter
Purchase of exclusive license - related party	`PaymentsToAcquireIntangibleAssets`	$25.00K	USD	1 Quarter
Purchase of exclusive license - related party	`PaymentsToAcquireIntangibleAssets`	-	USD	1 Quarter
Purchase of exclusive license - related party	`PaymentsToAcquireIntangibleAssets`	$884.71K	USD	24 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-25.00K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-884.71K	USD	24 Qtrs
Proceeds from convertible notes	`ProceedsFromConvertibleDebt`	-	USD	1 Quarter
Proceeds from convertible notes	`ProceedsFromConvertibleDebt`	-	USD	1 Quarter
Proceeds from convertible notes	`ProceedsFromConvertibleDebt`	$435.00K	USD	24 Qtrs
Cash repayment of convertible notes	`RepaymentsOfConvertibleDebt`	-	USD	1 Quarter
Cash repayment of convertible notes	`RepaymentsOfConvertibleDebt`	$15.00K	USD	24 Qtrs
Cash repayment of convertible notes	`RepaymentsOfConvertibleDebt`	-	USD	1 Quarter
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$305.67K	USD	1 Quarter
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$49.76K	USD	1 Quarter
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$8.35M	USD	24 Qtrs
Net cash from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$305.67K	USD	1 Quarter
Net cash from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$49.76K	USD	1 Quarter
Net cash from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$8.77M	USD	24 Qtrs
NET INCREASE (DECREASE) IN CASH	`CashPeriodIncreaseDecrease`	$288.71K	USD	24 Qtrs
NET INCREASE (DECREASE) IN CASH	`CashPeriodIncreaseDecrease`	$-375.43K	USD	1 Quarter
NET INCREASE (DECREASE) IN CASH	`CashPeriodIncreaseDecrease`	$-245.34K	USD	1 Quarter
Cash, beginning of period	`Cash`	$288.71K	USD	Point-in-time
Cash, beginning of period	`Cash`	$576.82K	USD	Point-in-time
Cash, beginning of period	`Cash`	$534.05K	USD	Point-in-time
Cash, beginning of period	`Cash`	-	USD	Point-in-time
Cash, beginning of period	`Cash`	$952.25K	USD	Point-in-time
Cash, end of period	`Cash`	$288.71K	USD	Point-in-time
Cash, end of period	`Cash`	$576.82K	USD	Point-in-time
Cash, end of period	`Cash`	$534.05K	USD	Point-in-time
Cash, end of period	`Cash`	-	USD	Point-in-time
Cash, end of period	`Cash`	$952.25K	USD	Point-in-time
Interest	`InterestPaid`	-	USD	1 Quarter
Interest	`InterestPaid`	$445.00	USD	24 Qtrs
Interest	`InterestPaid`	-	USD	1 Quarter
Income taxes	`IncomeTaxesPaid`	-	USD	24 Qtrs
Income taxes	`IncomeTaxesPaid`	-	USD	1 Quarter
Income taxes	`IncomeTaxesPaid`	-	USD	1 Quarter
Common stock issued upon conversion of convertible notes	`ConversionOfStockAmountConverted1`	-	USD	1 Quarter
Common stock issued upon conversion of convertible notes	`ConversionOfStockAmountConverted1`	-	USD	1 Quarter
Common stock issued upon conversion of convertible notes	`ConversionOfStockAmountConverted1`	$420.00K	USD	24 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.